EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 163 filers reported holding EMERGENT BIOSOLUTIONS INC in Q3 2023. The put-call ratio across all filers is 2.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $30,142 | -27.6% | 8,866 | +56.4% | 0.00% | – |
| Q2 2023 | $41,611 | +67.9% | 5,667 | +139.5% | 0.00% | – |
| Q1 2023 | $24,780 | -37.2% | 2,366 | -29.5% | 0.00% | – |
| Q4 2022 | $39,460 | -54.6% | 3,355 | -19.4% | 0.00% | – |
| Q3 2022 | $87,000 | -72.9% | 4,165 | -59.7% | 0.00% | -100.0% |
| Q2 2022 | $321,000 | -27.9% | 10,323 | -5.8% | 0.00% | 0.0% |
| Q1 2022 | $445,000 | -8.2% | 10,958 | -1.5% | 0.00% | 0.0% |
| Q4 2021 | $485,000 | -13.9% | 11,120 | -0.8% | 0.00% | 0.0% |
| Q3 2021 | $563,000 | -50.4% | 11,210 | -37.7% | 0.00% | -50.0% |
| Q2 2021 | $1,135,000 | +7.1% | 17,994 | +56.4% | 0.00% | -33.3% |
| Q1 2021 | $1,060,000 | -3.2% | 11,506 | -5.8% | 0.00% | 0.0% |
| Q4 2020 | $1,095,000 | -38.1% | 12,210 | -29.0% | 0.00% | -40.0% |
| Q3 2020 | $1,770,000 | +19.6% | 17,187 | -7.9% | 0.01% | 0.0% |
| Q2 2020 | $1,480,000 | +80.5% | 18,669 | +31.7% | 0.01% | +66.7% |
| Q1 2020 | $820,000 | – | 14,174 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zebra Capital Management LLC | 22,111 | $908,000 | 2.08% |
| Global Alpha Capital Management Ltd. | 460,530 | $18,909,000 | 1.62% |
| AIMZ Investment Advisors, LLC | 70,625 | $2,900,000 | 1.19% |
| Bridge City Capital, LLC | 39,835 | $1,636,000 | 0.76% |
| PALISADE CAPITAL MANAGEMENT, LP | 560,409 | $23,010,000 | 0.53% |
| EARNEST PARTNERS LLC | 2,071,376 | $85,051,000 | 0.50% |
| RICE HALL JAMES & ASSOCIATES, LLC | 302,721 | $12,430,000 | 0.50% |
| SummerHaven Investment Management, LLC | 14,476 | $594,000 | 0.34% |
| Ridgewood Investments LLC | 10,004 | $411,000 | 0.27% |
| AtonRa Partners | 11,505 | $472,000 | 0.26% |